- OctaplasmaTM Product Monograph, October 31, 2022

200 mL en sachets surgelés disponible dans les groupes sanguins A, B, O, AB
Maintenir congelé à ≤ -18 °C pendant 48 mois de durée de conservation
8 heures à une température de 20°C à 25°C, 5 jours à une température de 2°C à 8°C
Protéger de la lumière. Ne pas recongeler d’Octaplasma décongelé. Le produit non utilisé doit être jeté
Voir la monographie de produit pour obtenir des renseignements complets sur l’entreposage, la décongélation et la stabilité.
Please sign up here to receive email updates.
Standardized levels of neutralizing antibodies in the plasma pool minimize the risk of transmitting non-enveloped viruses (e.g., HAV, parvovirus B19, HEV).6
Standardized levels of neutralizing antibodies in the plasma pool minimize the risk of transmitting non-enveloped viruses (e.g., HAV, parvovirus B19, HEV).6
Change the color to match your brand or vision, add your logo, choose the perfect layout, modify menu settings, add animations, add shape dividers, increase engagement with call to action and more.
Change the color to match your brand or vision, add your logo, choose the perfect layout, modify menu settings and more.
Change the color to match your brand or vision, add your logo, choose the perfect layout, modify menu settings and more.
“Solvent-detergent treatment is the current gold standard for safety from the highly infectious enveloped viruses, and should be seriously considered as the option of choice when assessing products.” 3
"Solvent-detergent treatment is the current gold standard for safety from the highly infectious enveloped viruses..."3
"Solvent/detergent treatment is gentle on plasma proteins while effective in eliminating enveloped viruses."2
Solvent/detergent reagents irreversibly disrupt the lipid membranes of all enveloped viruses (e.g., SARS-CoV-2, HIV, HBV, HCV, HGV, and CMV).4
Standardized levels of neutralizing antibodies in the plasma pool minimize the risk of transmitting non-enveloped viruses (e.g., HAV, parvovirus B19, HEV).6
Standardized levels of neutralizing antibodies in the plasma pool minimize the risk of transmitting non-enveloped viruses (e.g., HAV, parvovirus B19, HEV).6
Adapted from Octapharma data on file.
Ce site Web contient des informations dont les professionnels de la santé auront besoin pour réussir la transition du plasma (PC) pour transfusion à l’Octaplasma, un plasma ayant subi une inactivation des agents pathogènes.